摘要
目的探讨康柏西普玻璃体腔内注射联合小梁切除术及视网膜光凝治疗新生血管性青光眼的疗效及安全性。方法对21例(21眼)玻璃体腔内注射康柏西普联合小梁切除术及视网膜光凝治疗新生血管性青光眼患者进行回顾性分析,通过常规眼科检查:视力、裂隙灯、房角镜、非接触眼压、彩色眼底照相以及眼底荧光血管造影(FFA)等,确诊患者为新生血管性青光眼。随后采用康柏西普玻璃体腔内注射联合小梁切除术及视网膜光凝方法对患者进行治疗,观察并对比患者术前、术后的视力和眼压。因被选患者术前视力差,主要观察治疗前、康柏西普玻璃体腔注射后1周、小梁切除术及视网膜光凝术后1、3、6个月眼压情况,采用单因素重复测量方差分析。结果治疗前眼压均值(46.5±5.2)mmHg(1kPa=7.5 mmHg),康柏西普玻璃体腔注射后1周眼压(35.4±4.4)mmHg,小梁切除术及视网膜光凝术后1、3、6个月眼压分别是(16.3±2.9)mmHg、(16.4±2.2)mmHg、(16.0±2.4)mmHg,术后1周、术后1个月眼压较治疗明显改善(F=127.72,P<0.01),差异具有统计学意义;治疗后1个月、3个月、6个月相比,差异无统计学意义。结论康柏西普玻璃体腔内注射联合小梁切除术及视网膜光凝治疗新生血管性青光眼能够有效降低眼压,保护残存视力,疗效安全可靠。
Objective To investigate the efficacy and safety of intravitreous injection of combercept combined with trabeculectomy and retinal photocoagulation for the treatment of neovascular glaucoma.Methods We performed a retrospective analysis of 21 patients(21 eyes)with neovascular glaucoma by intravitreous injection of combercept combined with trabeculectomy and retinal photocoagulation.Patients were diagnosed with neovascular glaucoma through routine ophthalmic examination,including visual acuity,slit lamp,gonioscopy,non-contact to intraocular pressure,color fundus photography,and fundus fluorescein angiography(FFA).Then intravitreous injection of combercept combined with trabeculectomy and retinal photocoagulation were used as the treatment.The implication of visual acuity and intraocular pressure were compared before and after the surgery.Due to poor vision of patients,intraocular pressure were mainly observed before treatment,1 week after intravitreal injection of combercept,1,3,and 6 months after the surgery of trabeculectomy and retinal photocoagulation.Then single factor repeated measurement were used to analyze the variance.Results Intraocular pressure was(46.5±5.2)mmHg(1 kPa=7.5 mmHg)before treatment,and intraocular pressure was(35.4±4.4)mmHg 1 week after the intravitreal injection of combercept.The intraocular pressure was(16.3±2.9)mmHg,(16.4±2.2)mmHg and(16.0±2.4)mmHg,at 1,3 and 6 months after trabeculectomy and retinal photocoagulation,respectively.The intraocular pressure(IOP)was significantly improved after 1 week and 1 month after operation(F=127.72,P〈0.01),which was statistically significant.The difference was not statistically significant at 1 month,3 months,and 6 months after treatment.Conclusion Combercept intravitreous injection combined with trabeculectomy and retinal photocoagulation for the treatment of neovascular glaucoma can effectively reduce intraocular pressure and protect residual vision.The curative effect is safe and reliable.
作者
张爱平
Zhang Aiping(Department of Ophthalmology,Nanyuan Hospital,Fengtai District,Beijing100076,China)
出处
《山西医药杂志》
CAS
2018年第15期1753-1755,共3页
Shanxi Medical Journal